Global Implantable Cardioverter Defibrillator (ICD) Devices Market Size, Share and Trends Analysis 2022-2028 MedCore Includes: Single-Chamber ICDs, Dual-Chamber ICDs,

In 2021, the global ICD market was valued at over $3.6 billion and is expected to grow at a CAGR of 4.1% to reach $4.7 billion by 2028.

Our medical market research analyzed ICD companies in over 70 countries and applied a comprehensive methodology to understand market size, unit sales, company market share, and generate accurate forecasts. This report encompasses the market for single-chamber ICDs, dual-chamber ICDs, and subcutaneous ICDs (S-ICDs).

MARKET REPORT DATA TYPES INCLUDED

• Unit Sales, Average Selling Prices, Market Size & Growth Trends
• Procedure Numbers
• COVID-19 Impact Analysis
• Market Drivers & Limiters
• Market Forecasts Until 2028, and Historical Data to 2018
• Recent Mergers & Acquisitions
• Company Profiles and Product Portfolios
• Leading Competitors

PROCEDURE NUMBERS

The global ICD market procedure numbers include both initial placement and replacement of single-chamber ICDs, dual-chamber ICDs, and S-ICDs. Despite the dip and recovery in 2020 and 2021 due to postponed elective procedures, the total number of ICD procedures is expected to grow at a moderate single-digit rate during the forecast period.

GLOBAL ICD MARKET TRENDS

The cardiac resynchronization therapy (CRT) device market saw an increase in 2021 compared to the previous year. Although CRTs are the costliest device category within the CRM industry, their added benefits over implantable cardioverter defibrillators (ICDs) make them appealing, overcoming the price difference.

GLOBAL ICD MARKET SHARE INSIGHTS

Medtronic, Abbott, and Boston Scientific were the leading players in the global ICD market. In 2021, Medtronic dominated the market with single-chamber and dual-chamber devices and has a long history of being a leading manufacturer in the ICD industry. Medtronic offers a range of pacemakers, including CobaltTM, CromeTM, EveraTMMRI and others.

GLOBAL ICD MARKET SEGMENTATION SUMMARY

• Single-chamber ICDs
• Dual-chamber ICDs
• Subcutaneous ICDs

RESEARCH SCOPE SUMMARY

• Regions: North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
• Base Year: 2021
• Forecast: 2022-2028
• Historical Data: 2018-2021
• Quantitative Coverage: Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
• Qualitative Coverage: COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
• Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, Internal Database.